Acer Medical Inc. (TPEX:6857)
Taiwan · Delayed Price · Currency is TWD 95.50
-0.50 (-0.52%)
At close: Jun 12, 2026
Acer Medical Market Cap
Acer Medical has a market cap or net worth of 1.45 billion as of June 12, 2026. Its market cap has decreased by -39.56% in one year.
Market Cap
1.45B
Enterprise Value
1.28B
Revenue
60.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
95.50
Market Cap Chart
Since October 27, 2021, Acer Medical's market cap has increased from 720.00M to 1.45B, an increase of 101.96%. That is a compound annual growth rate of 16.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 1.45B | -3.54% |
| Dec 31, 2025 | 1.51B | -30.28% |
| Dec 30, 2024 | 2.16B | -23.66% |
| Dec 29, 2023 | 2.83B | 154.79% |
| Dec 30, 2022 | 1.11B | -1.98% |
| Dec 21, 2021 | 1.13B | 57.50% |
| Oct 27, 2021 | 720.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 352.67B |
| Caliway Biopharmaceuticals | 144.28B |
| Heron Neutron Medical | 54.50B |
| Lotus Pharmaceutical | 51.64B |
| NeoCore Technology | 1.50B |
| Great Novel Therapeutics Biotech & Medicals | 1.49B |
| Advagene Biopharma | 1.48B |
| GeneFerm Biotechnology | 1.43B |